[1]
Bonanni, P. et al. 2012. HPV vaccination and allocative efficiency: regional analysis of the costs and benefits with the bivalent AS04-adjuvanted vaccine, from the perspective of public health, for the prevention of cervical cancer and its pre-cancerous lesions. Farmeconomia. Health economics and therapeutic pathways. 13, 2S (Nov. 2012), 3–15. DOI:https://doi.org/10.7175/fe.v13i2S.449.